Treace Medical Concepts TMCI
NASDAQ TMCI
$4.35 -0.11 (-2.47%)
As of: Aug 21, 2026 · 3:59 PM EDT

Treace Medical Concepts (TMCI) Operating Margin Growth (3y) (2023 - 2026)

Treace Medical Concepts (TMCI) Operating Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -201.00
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 586.00
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 78.00
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 736.00
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 887.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 963.00
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn 212.00
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 535.00
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 244.00
10 Treace Medical Concepts 283.62 Mn 238.00 Mn 35.61 Mn -185.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -185.00
Mar 31, 2026 -372.00
Dec 31, 2025 -245.00
Sep 30, 2025 302.00
Jun 30, 2025 400.00
Mar 31, 2025 -177.00
Dec 31, 2024 1,644.00
Sep 30, 2024 -831.00
Jun 30, 2024 -2,848.00
Mar 31, 2024 -2,962.00
Dec 31, 2023 -2,598.00
Sep 30, 2023 -4,327.00
Jun 30, 2023 -1,150.00
Mar 31, 2023 -2,200.00